Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: An integrated data analysis

Epidemiology and Infection

Volumn 144, Issue 6, 2016, Pages 1345-1354

  Guo, C T ^a,b   Lu, Q B ^c   Ding, S J ^d   Hu, C Y ^a   Hu, J G ^a   Wo, Y ^a   Fan, Y D ^a   Wang, X J ^d   Qin, S L ^e   Cui, N ^e   Yang, Z D ^e   Zhang, X A ^a   Liu, W ^a,b   Cao, W C ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^d Shandong Provincial Key Lab of Dermato venereology   (China)

^e The 154 Hospital   (China)

Author keywords

Bunyavirus; China; meta analysis; severe fever with thrombocytopenia syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; CREATINE KINASE; LACTATE DEHYDROGENASE;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; CHILL; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FATALITY; FEMALE; FEVER; HUMAN; INCIDENCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; MYALGIA; SEROPREVALENCE; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; SEX DIFFERENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ASYMPTOMATIC INFECTIONS; BUNYAVIRIDAE INFECTIONS; COMMUNICABLE DISEASES, EMERGING; HOSPITALIZATION; META ANALYSIS; MORTALITY; PHLEBOVIRUS; PHYSIOLOGY; PREVALENCE; SOCIOECONOMICS; VIROLOGY;

ADULT; AGED; ASYMPTOMATIC INFECTIONS; BUNYAVIRIDAE INFECTIONS; CHINA; COMMUNICABLE DISEASES, EMERGING; FEMALE; FEVER; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHLEBOVIRUS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; THROMBOCYTOPENIA;

EID: 84946761867     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815002678     Document Type: Article

References (45)

1. Yu XJ, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. New England Journal of Medicine 2011; 364: 1523-1532.
2. Liu K, et al. A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Scientific Reports 2015; 5: 9679.
3. Liu Q, et al. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infectious Diseases 2014; 14: 763-772.
4. Kim KH, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerging Infectious Diseases 2013; 19: 1892-1894.
5. Takahashi T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. Journal of Infectious Diseases 2014; 209: 816-827.
6. Bao CJ, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clinical Infectious Diseases 2011; 53: 1208-1214.
7. Chen H, et al. A cluster of cases of human-to-human transmission caused by severe fever with thrombocytopenia syndrome bunyavirus. International Journal of Infectious Diseases 2013; 17: e206-208.
8. Tang X, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. Journal of Infectious Diseases 2013; 207: 736-739.
9. Wang Y, et al. Person-to-person asymptomatic infection of severe fever with thrombocytopenia syndrome virus through blood contact. Internal Medicine (Tokyo, Japan) 2014; 53: 903-906.
10. Deng B, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS ONE 2013; 8: e80802.
11. Gai ZT, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. Journal of Infectious Diseases 2012; 206: 1095-1102.
12. Zhang YZ, et al. Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clinical Infectious Diseases 2012; 54: 527-533.
13. Liu W, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clinical Infectious Diseases 2013; 57: 1292-1299.
14. Liu K, et al. Epidemiologic features and environmental risk factors of severe fever with thrombocytopenia syndrome, Xinyang, China. PLoS Neglected Tropical Diseases 2014; 8: e2820.
15. Ding F, et al. Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011-2012. Clinical Infectious Diseases 2013; 56: 1682-1683.
16. Ministry of Health, China. Guideline for prevention and treatment of severe fever with thrombocytopenia syndrome (2010 version). Chinese Journal of Clinical Infectious Diseases 2011; 4: 193-194.
17. Zhang YZ, et al. Hemorrhagic fever caused by a novel tick-borne Bunyavirus in Huaiyangshan, China. Chinese Journal of Epidemiology 2011; 32: 209-220.
18. Zhang YY, et al. Clinical features of fever with thrombocytopenia syndrome: report of 16 cases. Chinese Journal of Clinical Infectious Diseases 2012; 5: 89-90.
19. Zhang YG, et al. Clinical characteristics and epidemiology of novel bunyavirus human infection cases in Dandong city, 2010-2012. Chinese Journal of Public Health 2013; 29: 201-204.
20. Zhang XL, et al. Nursing care of 15 patients infected by novel Bunyavirus. Chinese Nursing 2012; 47: 123-124.
21. Zhang WS, et al. Seroepidemiology of severe with thrombocytopenia syndrome bunyavirus in Jiangsu province. Disease Surveillance 2011; 26: 676-678.
22. Zhang SP, et al. Clinical analysis of 12 cases of SFTSV infected by novel bunyavirus. Jiangsu Medical Journal 2012; 38: 583-584.
23. Zhang L, et al. Antibodies against severe fever with thrombocytopenia syndrome virus in healthy persons, China, 2013. Emerging Infectious Diseases 2014; 20: 1355-1357.
24. Yu B, et al. Epidemiological study on data involving 61 hospitalized cases with Huaiyangshan hemorrhagic fever in Wuhan. Chinese Journal of Epidemiology 2012; 33: 124-125.
25. Xia YJ, et al. Clinical analysis of 12 cases associated hemophagocytic comprehensive with novel bunyavirus syndrome infected. Journal of Clinical Internal Medicine 2013; 30: 487-488.
26. Wang L, et al. Surveillance and analysis of severe fever with thrombocytopenia syndrome in Zibo City. Modern Preventive Medicine 2013; 40: 3471-3474.
27. Sun JM, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factors. Epidemiology and Infection 2015; 143: 851-856.
28. Sun J, et al. Epidemiological characteristics of severe fever with thrombocytopenia syndrome in Zhejiang Province, China. International Journal of Infectious Diseases 2014; 25: 180-185.
29. Song LH, et al. Epidemiological characteristics and control strategy of patients infected by SFTSV in Dalian, China. Chinese Journal of Pest Control 2012; 28: 1325-1327.
30. Shen LM, et al. 13 cases of the new virus infection nursing experience in acute stage. Zhejiang Medical Journal 2013; 35: 2222-2224.
31. Qiu YQ. Nursing care of patients infected by novel bunyavirus. Chinese Journal of Practical Nursing 2012; 28: 78-79.
32. Long ZG, et al. Clinical analysis of 11 cases with a new variety of bunyavirus infection. Journal of Internal Intensive Medicine 2011; 17: 340-342.
33. Liu Y, et al. Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne and Zoonotic Diseases (Larchmont, NY) 2012; 12: 156-160.
34. Liu L, et al. Epidemiologic analysis on severe fever with thrombocytopenia syndrome in Hubei province, 2010. Chinese Journal of Epidemiology 2012; 33: 168-172.
35. Liang S, et al. Seroprevalence and risk factors for severe fever with thrombocytopenia syndrome virus infection in Jiangsu Province, China, 2011. American Journal of Tropical Medicine and Hygiene 2014; 90: 256-259.
36. Li Z, et al. Seroprevalence of antibodies against SFTS virus infection in farmers and animals, Jiangsu, China. Journal of Clinical Virology 2014; 60: 185-189.
37. Jiao Y, et al. Preparation and evaluation of recombinant severe fever with thrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies in human and animal sera by double-antigen sandwich enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 2012; 50: 372-377.
38. Huang X, et al. Epidemiological and etiological characteristics of fever, thrombocytopenia and leukopenia syndrome in Henan Province, China, 2011-2012. PLoS ONE 2014; 9: e91166.
39. Hu JL, et al. Clinical and epidemiological characteristics on 20 cases of SFTSV infection. Chinese Journal of Zoonoses 2012; 28: 302-305.
40. Hu C, et al. The severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) antibody in a highly endemic region from 2011 to 2013: A comparative serological study. American Journal of Tropical Medicine and Hygiene 2015; 92: 479-481.
41. Han MF, et al. Clinical features and nursing care of patients infected by SFTSV in Zhoushan area. Journal of Modern Nursing 2013; 19: 1901-1903.
42. Gong LF, et al. Prevalence and homology analysis on human and animals severe fever with thrombocytopenia syndrome virus infection in Yantai of Shandong province. Chinese Journal of Epidemiology 2014; 35: 524-527.
43. Ding YP, et al. Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clinical Microbiology and Infection 2014; 20: 870-878.
44. Cui F, et al. Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China. American Journal of Tropical Medicine and Hygiene 2013; 88: 510-512.
45. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nature Reviews Immunology 2008; 8: 737-744.